Back to
Avoro Capital Advisors LLC
RAREShowing 5 of 15 quarters
Position history for
Avoro Capital Advisors LLC's holdings in Ultragenyx Pharmaceutical, Inc.
Avoro Capital Advisors LLC previously held 0 shares of RARE (Ultragenyx Pharmaceutical, Inc.), worth $0 as of 2025-Q3.
Final Value
$0
Final Shares
0
Total Value Change
-$46.1M
Total Shares Change
-830,000
Quarter-by-Quarter History
Other major holders of RARE: Capital Research Global Investors, BNP PARIBAS FINANCIAL MARKETS, Capital International Investors